Stem Cell Therapy Market Size, Share, Trends & Competitive Analysis By Type of Stem Cell (Adult Stem Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells, Other Stem Cells, By Therapeutic Application; By Treatment Mode; By End User; By Regions, and Industry Forecast, Global Report 2023-2030

The global Stem Cell Therapy Market size was valued at USD 13.57 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 14.5% during the forecast period, reaching a value of USD 36.97 billion by 2030.

Stem Cell Therapy Market research report by Future Data Stats, offers a comprehensive view of the market's historical data from 2017 to 2021, capturing trends, growth patterns, and key drivers. It establishes 2021 as the base year, analyzing the market landscape, consumer behavior, competition, and regulations. Additionally, the report presents a well-researched forecast period from 2022 to 2030, leveraging data analysis techniques to project the market's growth trajectory, emerging opportunities, and anticipated challenges.


Stem Cell Therapy is a cutting-edge medical approach that utilizes the unique properties of stem cells to treat a variety of diseases and conditions. Stem cells are undifferentiated cells that have the potential to develop into different cell types in the body. This therapy involves the transplantation or injection of these cells into damaged tissues or organs to stimulate repair and regeneration. Stem Cell Therapy holds immense promise in the field of regenerative medicine and has shown potential for treating musculoskeletal disorders, cardiovascular diseases, neurological disorders, wound healing, oncology, ophthalmology, and more.

The research surrounding Stem Cell Therapy focuses on understanding the behavior of stem cells, exploring their therapeutic applications, and developing safe and effective techniques for their use in clinical settings. This area of study aims to unlock the full potential of stem cells and revolutionize the treatment of various debilitating conditions, providing new hope for patients worldwide.


Firstly, the increasing prevalence of chronic diseases and degenerative disorders has created a growing demand for advanced treatment options. Stem Cell Therapy offers a potential solution by harnessing the regenerative capabilities of stem cells to repair damaged tissues and organs. This has fueled the adoption of stem cell-based treatments across various therapeutic areas, including musculoskeletal disorders, cardiovascular diseases, and neurodegenerative conditions. Additionally, the advancements in stem cell research and technology have improved the safety and efficacy of these therapies, further driving market growth.

However, the Stem Cell Therapy market also faces certain restraints. One major challenge is the high cost associated with stem cell treatments, which limits their accessibility for a large population. Moreover, ethical concerns surrounding the use of embryonic stem cells have led to regulatory restrictions in some regions, impeding market expansion. Additionally, the complex and lengthy regulatory approval processes for stem cell therapies pose a barrier to market growth.

Despite these challenges, the Stem Cell Therapy market presents significant opportunities for future growth. Ongoing research and development efforts aim to enhance the understanding of stem cell biology, improve manufacturing techniques, and expand the range of therapeutic applications. Furthermore, collaborations between industry players and academic institutions are fostering innovation and driving the development of novel stem cell-based therapies. The emergence of personalized medicine and the increasing focus on regenerative medicine hold immense potential for the expansion of the Stem Cell Therapy market in the coming years.



Adult stem cells, which are found in various tissues and organs of the body, play a crucial role in regenerative medicine. They offer advantages such as ease of collection, reduced ethical concerns, and compatibility with the patient's own cells, making them a widely adopted option for therapeutic applications. Embryonic stem cells, derived from early-stage embryos, possess remarkable pluripotency and the ability to differentiate into any cell type in the body. Despite ethical considerations and regulatory restrictions, they continue to be studied for their potential in treating various diseases. Induced pluripotent stem cells (iPSCs), created through reprogramming adult cells, have garnered significant attention due to their ability to bypass ethical concerns associated with embryonic stem cells while offering similar regenerative potential.

Other stem cells, including perinatal stem cells and mesenchymal stem cells, also contribute to the diverse landscape of stem cell therapy, offering unique advantages in terms of availability, immunomodulatory properties, and ease of isolation. These dominant factors related to the types of stem cells utilized in therapies shape the Stem Cell Therapy market by influencing treatment approaches, research focus, and regulatory considerations.


Musculoskeletal disorders, such as arthritis and orthopedic injuries, represent a significant segment for stem cell-based treatments, as these therapies aim to enhance tissue repair and regeneration. Cardiovascular diseases, including myocardial infarction and heart failure, present a promising avenue for stem cell therapy, with efforts focused on improving cardiac function and promoting tissue healing. Neurological disorders, encompassing conditions like Parkinson's disease and spinal cord injuries, highlight the potential of stem cells in regenerating damaged nerve tissues and restoring neurological function. Wound healing, a critical aspect of healthcare, is another important therapeutic application where stem cell therapies show promise in accelerating the healing process and improving outcomes. The field of oncology is exploring stem cell therapy for cancer treatment, focusing on targeted therapies and immunomodulation to combat the disease. Ophthalmology represents a niche area where stem cell-based interventions aim to address vision-related disorders, such as corneal damage and retinal degeneration. Additionally, stem cell therapies are being explored for a wide range of other medical conditions, including autoimmune disorders and metabolic diseases. The dominant factors associated with these diverse therapeutic applications shape the Stem Cell Therapy market, driving research and development efforts, clinical trials, and commercialization strategies to cater to the specific needs of each medical domain.


allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell therapy involves the use of stem cells sourced from a donor other than the patient, either from a related or unrelated donor or from stem cell banks. This treatment mode offers advantages such as availability, reduced cost, and potential for off-the-shelf therapies. Autologous stem cell therapy, on the other hand, utilizes stem cells obtained from the patient's own body, typically from bone marrow or adipose tissue. This approach offers the advantage of compatibility and reduced risk of rejection or immune response.

The dominant factors associated with these treatment modes shape the Stem Cell Therapy market by influencing factors such as treatment accessibility, cost-effectiveness, safety considerations, and regulatory requirements. The choice between allogeneic and autologous stem cell therapy depends on several factors, including the specific medical condition, patient characteristics, and the availability of suitable stem cell sources.


Hospitals and clinics play a pivotal role as primary providers of stem cell treatments, offering a direct avenue for patients to access these therapies. These healthcare facilities are key stakeholders in the market, driving the adoption of stem cell therapies and contributing to the overall growth of the industry. Stem cell banks serve as crucial intermediaries by storing and preserving stem cell samples for future therapeutic use. They provide a valuable resource for both allogeneic and autologous stem cell therapies, ensuring a readily available supply of stem cells for patients in need. Research institutes are vital contributors to the Stem Cell Therapy market, driving innovation and advancements in stem cell research. These institutions conduct rigorous studies, preclinical trials, and clinical trials to expand the knowledge base and explore new therapeutic applications. Additionally, other stakeholders such as biotechnology companies, regenerative medicine companies, and governmental organizations also play a role in shaping the market by contributing to research, development, and regulation.


North America, with its well-established healthcare infrastructure and extensive research and development activities, holds a dominant position in the Stem Cell Therapy market. The region benefits from a favorable regulatory environment and substantial investments in stem cell research, leading to the commercialization of innovative therapies. Europe follows closely, with countries such as Germany, the UK, and France driving market growth through advanced healthcare systems and supportive government initiatives.

The Asia Pacific region, particularly countries like China, Japan, and South Korea, is emerging as a significant market player due to rising investments in stem cell research, growing healthcare infrastructure, and a large patient pool. Additionally, Latin America and the Middle East and Africa regions are also witnessing steady growth, with increasing awareness about the potential of stem cell therapies and the establishment of research centers and healthcare facilities.


The COVID-19 pandemic has had a significant impact on the Stem Cell Therapy market from a market research point of view. The outbreak of the virus has resulted in disruptions across various sectors, including healthcare and life sciences. Stem Cell Therapy, being a novel and advanced medical approach, faced both challenges and opportunities during this crisis. On one hand, the pandemic led to temporary disruptions in clinical trials, delayed research activities, and diverted healthcare resources towards managing COVID-19 cases. On the other hand, the pandemic highlighted the importance of regenerative medicine and the potential of stem cell therapies in treating severe respiratory complications and promoting tissue repair in COVID-19 patients. The crisis also accelerated the adoption of telemedicine and digital healthcare platforms, enabling remote consultations and monitoring of patients undergoing stem cell treatments.

The market research perspective on the Stem Cell Therapy market during COVID-19 involves studying the impact on research and development, clinical trials, regulatory considerations, patient access, and market dynamics. It also entails identifying the emerging trends and opportunities that arise from the integration of stem cell therapies in the management of COVID-19-related complications. Understanding the COVID-19 impact is crucial for stakeholders to navigate the market landscape, adapt to the changing environment, and contribute to the ongoing efforts to address the healthcare challenges posed by the pandemic.


Mergers & Acquisitions:

  • In October 2022, Medipost announced the launch of its CDMO business for cell and gene therapy products in Korea.
  • In September 2022, Caladrius Biosciences, Inc. and Cend Therapeutics, Inc. merged to form Lisata Therapeutics, Inc.
  • In June 2023, Allogene Therapeutics, Inc. acquired CAR T-cell therapy company Poseida Therapeutics, Inc.

Product New Launches:

  • In January 2023, Mesoblast Limited launched remestemcel-L (Remestem) for the treatment of knee osteoarthritis in the United States.
  • In March 2023, Shire plc launched CryoSpen (Cryopreserved allogeneic mesenchymal stem cells) for the treatment of chronic low back pain in the European Union.
  • In April 2023, TiGenix NV launched ChondroCelect (chondrocytes) for the treatment of cartilage defects in the knee in the European Union.


  • Novartis AG
  • Gilead Sciences, Inc.
  • Mesoblast Limited
  • Vericel Corporation
  • Osiris Therapeutics, Inc.
  • TiGenix NV
  • Astellas Pharma Inc.
  • Celgene Corporation
  • Thermo Fisher Scientific Inc.
  • Lonza Group Ltd.
  • Pluristem Therapeutics Inc.
  • Athersys, Inc.
  • Medipost Co., Ltd.
  • Cytori Therapeutics, Inc.
  • Brainstorm Cell Therapeutics Inc.
  • NuVasive, Inc.
  • Pharmicell Co., Ltd.
  • StemCells Inc.
  • Cellular Dynamics International, Inc.
  • Fate Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Cyagen Biosciences Inc.
  • Cynata Therapeutics Limited
  • ViaCyte, Inc.

Table of Contents

1.1. Definition and Overview
1.2. Research Methodology

Executive Summary

Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Trends

Stem Cell Therapy Market Analysis, by Type of Stem Cell
4.1. Adult Stem Cells
4.2. Embryonic Stem Cells
4.3. Induced Pluripotent Stem Cells (iPSCs)
4.4. Other Stem Cells

Stem Cell Therapy Market Analysis, by Therapeutic Application
5.1. Musculoskeletal Disorders
5.2. Cardiovascular Diseases
5.3. Neurological Disorders
5.4. Wound Healing
5.5. Oncology
5.6. Ophthalmology
5.7. Others

Stem Cell Therapy Market Analysis, by Treatment Mode
6.1. Allogeneic Stem Cell Therapy
6.2. Autologous Stem Cell Therapy

Stem Cell Therapy Market Analysis, by End User
7.1. Hospitals and Clinics
7.2. Stem Cell Banks
7.3. Research Institutes
7.4. Others

Stem Cell Therapy Market Analysis, by Region
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East and Africa

Competitive Landscape
9.1. Company Profiles
9.2. Market Share Analysis


11.1. List of Abbreviations
11.2. Sources and References


By Type of Stem Cell:

  • Adult Stem Cells
  • Embryonic Stem Cells
  • Induced Pluripotent Stem Cells (iPSCs)
  • Other Stem Cells

By Therapeutic Application:

  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Neurological Disorders
  • Wound Healing
  • Oncology
  • Ophthalmology
  • Others

By Treatment Mode:

  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy

By End User:

  • Hospitals and Clinics
  • Stem Cell Banks
  • Research Institutes
  • Others


By Geography:

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Reasons to Buy this Report

  • Comprehensive Insights: Market research reports provide in-depth and comprehensive insights into various industries, markets, and sectors. These reports are prepared after extensive data collection, analysis, and interpretation, offering you valuable information and a clear understanding of market trends, dynamics, and opportunities.
  • Future Predictions: Market research reports often include future data statistics, forecasts, and predictions. These predictions are based on rigorous analysis and modeling techniques, taking into account various factors such as market growth drivers, challenges, and emerging trends. By accessing these future data stats, you can make informed decisions and develop strategies that align with the projected market scenarios.
  • Industry Analysis: Market research reports offer detailed industry analysis, including factors such as market size, market share, competitive landscape, and key players. These reports provide an overview of the industry's current status, growth potential, and competitive dynamics, enabling you to identify lucrative opportunities and stay ahead of the competition.
  • Market Trends and Opportunities: By purchasing market research reports, you gain access to up-to-date information on market trends and emerging opportunities. These reports highlight the latest consumer preferences, technological advancements, regulatory changes, and other influential factors shaping the market landscape. Keeping track of these trends helps you identify potential growth areas and adapt your business strategies accordingly.
  • Risk Mitigation: Investing in a market research report can help mitigate risks associated with market uncertainties. The reports provide insights into potential risks, challenges, and barriers to entry in specific markets or industries. With this knowledge, you can develop risk mitigation strategies, anticipate market fluctuations, and make informed decisions to minimize potential losses.
  • Investment Decision Support: Market research reports are valuable tools for investors, venture capitalists, and financial institutions. These reports provide reliable and data-driven information that aids in investment decision-making processes. By analyzing market research reports, investors can evaluate the market potential, assess the feasibility of investment opportunities, and gauge the expected returns on investment.
  • Product Development and Innovation: Market research reports offer insights into consumer preferences, needs, and demands. This information can be leveraged for product development and innovation. By understanding the market dynamics and consumer behavior, you can tailor your products or services to meet the evolving needs of your target audience, leading to enhanced customer satisfaction and market success.
  • Strategic Planning: Market research reports serve as a foundation for strategic planning. They provide a comprehensive overview of the market landscape, competitive positioning, and growth potential. With this knowledge, you can develop effective business strategies, set realistic goals, and allocate resources efficiently. Strategic planning based on accurate market research helps optimize your operations and improve your chances of success.
  • Market Entry and Expansion: For businesses looking to enter new markets or expand their existing operations, market research reports are indispensable. These reports provide insights into market dynamics, consumer behavior, regulatory frameworks, and competitive landscapes specific to the target markets. This information helps you assess the feasibility of market entry, identify potential obstacles, and develop market entry strategies that increase your chances of success.
  • Evidence-Based Decision Making: Market research reports provide evidence-based data and analysis, enabling you to make informed decisions. Rather than relying on assumptions or guesswork, you can base your decisions on reliable information and market insights. Evidence-based decision making reduces the risk of costly mistakes and increases the likelihood of achieving your business objectives.


With a collective industry experience of about 70 years of analysts and experts, Future Data Stats encompasses the most infallible research methodology for its market intelligence and industry analysis. Not only does the company dig deep into the innermost levels of the market, but also examines the minutest details for its market estimates and forecasts.

This approach helps build a greater market-specific view of size, shape, and industry trends within each industry segment. Various industry trends and real-time developments are factored into identifying key growth factors and the future course of the market. The research proceeds are the results of high-quality data, expert views & analysis, and valuable independent opinions. The research process is designed to deliver a balanced view of the global markets and allows stakeholders to make informed decisions, to attain their highest growth objectives.

Future Data Stats offers its clients exhaustive research and analysis, based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models distill the data & statistics and enhance the accuracy of our recommendations and advice.

With Future Data Stats calibrated research process and 360° data-evaluation methodology, the clients receive:

  • Consistent, valuable, robust, and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through a well-audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of the marketplace

With this strong methodology, Future Data Stats ensures that its research and analysis is most reliable and guarantees sound business planning.

The research methodology of the global market involves extensive primary and secondary research. Primary research includes about 24 hours of interviews and discussions with a wide range of stakeholders that include upstream and downstream participants. Primary research typically is a bulk of our research efforts, coherently supported by extensive secondary research. Over 3000 product literature, industry releases, annual reports, and other such documents of key industry participants have been reviewed to obtain a better market understanding and gain enhanced competitive intelligence. In addition, authentic industry journals, trade associations’ releases, and government websites have also been reviewed to generate high-value industry insights.

Primary Research:

Primary Research


Desk Research


Company Analysis


•       Identify key opinion leaders

•       Questionnaire design

•       In-depth Interviews

•       Coverage across the value chain


•       Company Website

•       Company Annual Reports

•       Paid Databases

•       Financial Reports


•       Market Participants

•       Key Strengths

•       Product Portfolio

•       Mapping as per Value Chain

•       Key focus segment


Primary research efforts include reaching out to participants through emails, telephonic conversations, referrals, and professional corporate relations with various companies that make way for greater flexibility in reaching out to industry participants and commentators for interviews and discussions.

The aforementioned helps to:

  • Validate and improve data quality and strengthen the research proceeds
  • Develop a market understanding and expertise
  • Supply authentic information about the market size, share, growth, and forecasts

The primary research interview and discussion panels comprise experienced industry personnel.

These participants include, but are not limited to:

  • Chief executives and VPs of leading corporations specific to an industry
  • Product and sales managers or country heads; channel partners & top-level distributors; banking, investments, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research:

A broad array of industry sources for the secondary research typically includes, but is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor  presentations for a competitive scenario and shape of the industry
  • Patent and regulatory databases to understand technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles, web-casts, and other related releases to evaluate the market
  • Internal and external proprietary databases, key market indicators, and relevant press releases for  market estimates and forecasts



•       Top executives of end-use industries

•       C-level executives of the leading Parenteral Nutrition companies

•       Sales manager and regional sales manager of the Parenteral Nutrition companies

•       Industry Consultants

•       Distributors/Suppliers


•       Annual Reports

•       Presentations

•       Company Websites

•       Press Releases

•       News Articles

•       Government Agencies’ Publications

•       Industry Publications

•       Paid Databases


Analyst Tools and Models:



·         Arriving at
Global Market Size

·         Arriving at
Market Size

·         Market Share
of Key Players

·         Key Market Players

·         Key Market Players

·         Market Share
of Key Players

·         Arriving at
Market Size

·         Arriving at
Global Market Size




  • Increasing prevalence of chronic diseases and degenerative disorders
  • Growing demand for regenerative medicine and personalized treatments
  • Advancements in stem cell research and technology
  • Potential to address unmet medical needs
  • Supportive government initiatives and funding for stem cell research


  • High costs associated with stem cell therapies
  • Ethical concerns and regulatory restrictions surrounding embryonic stem cells
  • Complex and lengthy regulatory approval processes
  • Limited reimbursement policies and insurance coverage
  • Challenges in scaling up production and standardizing manufacturing processes


  • Expanding therapeutic applications in musculoskeletal disorders, cardiovascular diseases, and neurological disorders
  • Development of novel stem cell-based treatments for oncology and wound healing
  • Advancements in tissue engineering and 3D bioprinting technologies
  • Growing investments in stem cell research and development
  • Potential for international collaborations and partnerships


  • Limited long-term safety and efficacy data of stem cell therapies
  • Need for improved clinical trial designs and standardized outcome measures
  • Public perception and awareness of stem cell therapy
  • Intellectual property rights and patent issues
  • Ethical considerations and regulatory compliance in different regions

Frequently Asked Questions

The global Stem Cell Therapy Market size was valued at USD 13.57 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 14.5% during the forecast period, reaching a value of USD 36.97 billion by 2030.

The increasing prevalence of chronic diseases and degenerative disorders, advancements in stem cell research and technology, growing demand for regenerative medicine, supportive government initiatives, and potential to address unmet medical needs.

The development of novel therapeutic applications, such as in musculoskeletal disorders, cardiovascular diseases, and neurological disorders. There is also ongoing research in tissue engineering, 3D bioprinting, and personalized medicine. Additionally, collaborations between academia and industry, as well as the integration of stem cell therapies in COVID-19 management, are notable trends.

North America, Europe, and the Asia Pacific region, including countries like the United States, Germany, and China, are expected to dominate the Stem Cell Therapy market due to their well-established healthcare infrastructure, supportive regulatory frameworks, and significant investments in research and development.

The high treatment costs, ethical concerns surrounding embryonic stem cells, complex regulatory processes, limited reimbursement policies, and challenges in scaling up production. However, there are opportunities for growth in expanding therapeutic applications, advancements in manufacturing processes, international collaborations, and the potential to address unmet medical needs.
Why Future Data Stats?
Examine Of Marketplace

Your Commercial Enterprise Can Develop Primarily Based On Exclusive Research Results, Along Side Insightful Services. It's Going To Also Allow You To Recognize Diverse Marketing Updates And Different Brand In A Extra Efficient Way.

1+ Million Marketplace Research Report

we performs all the essential studies and provide commonly accurate, result oriented income statistics, market facts, and data marketplace scenarios of the past and future. with experience of over 10 years our research report library cover collection of one million plus reports.

Prediction about the Worldwide Marketplace

so as to gain information on the worldwide markets future data stats offer most correct market prediction using both pessimistic view to benefit truthful concept of future development.

Traditional and Hybrid Methodologies

future data stats presents a holistic and extra accurate view of the marketplace through a aggregate of secondary and primary research and hybrid methodologies.